Article Details

Months away from completing a key sickle cell trial, upstart Imara scores $63M in round co-led by ...

Retrieved on: 2019-03-17 18:28:12

Tags for this article:

Click the tags to see associated articles and topics

Months away from completing a key sickle cell trial, upstart Imara scores $63M in round co-led by .... View article details on HISWAI:

Excerpt

<div>... and Lundbeck — with $31 million in Series A funding from a slew of investors, including <b>New Enterprise Associates</b> and Pfizer Venture Investments.</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up